Overview
Cloverleaf Bio, a New Haven, CT-based provider of engineered transfer RNA (tRNA) based payloads for cancer, raised $33M in Seed funding. The round was led by 4BIO Capital with participation from AbbVie Ventures, Eli Lilly and Company, Boehringer Ingelheim Venture Fund, Draper Associates, Mission BioCapital, and American Cancer Society BrightEdge....See more
Website
https://cloverleafbio.com/Headquarters
New Haven, CT
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$33.0M • Seed
Announced on 9/8/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.